Recombinant monoclonal antibody to dll4. Clone 21H3 is a IgG1 that can be potentially used in the treatment of diseases associated with the activity and/or overproduction of DLL4 and as diagnostics.
Figure 1 The effects of IgGl DLL4 antibodies on DLL4-stimulated inhibition of HUVEC proliferation.
Data is representative of n>2 independent experiments.
Figure 2 The effects of IgG2/4 DLL4 antibodies on HUVEC tube formation in vitro as assessed by measurement of vessel length (mm) and # bifurcations.
Figure 3 The effects of unlabeled anti-DLL4 antibodies to displace the binding of Alexa-647 labeled 21H3RK at 0.1 mg/ml as determined by FACS analysis
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-204 | Anti-Human DLL4 Recombinant Antibody (TAB-204) | ELISA, FC, IP, FuncS, IF, Neut, WB | IgG2 - kappa |
There are currently no Customer reviews or questions for HPAB-0152-LSX. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.